Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.9 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.9 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |